Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin versus placebo for central neuropathic pain
NL-OMON26939Active, not recruiting
- Sponsor
- Academic Medical Center
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in central neuropathic pain (CNP) comparing Pregabalin with Placebo (2 arms). Primary endpoint: Pain intensity score. Started Jan 2006; status: active, not recruiting.
02
Drugs
pregabalin
03
Conditions
central neuropathic pain (CNP)
Beyond the preview
Go deeper on NL-OMON26939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26939.